Skip to main content
. 2013 Jul 12;27(4):253–260. doi: 10.1002/jcla.21588

Figure 1.

Figure 1

Levels of plasma (A) LCN2 and (B) LCN2/MMP‐9 complex in 61 patients with community‐acquired pneumonia (CAP) and 60 control subjects, as measured by an ELISA analysis before and after antibiotic treatment. (A) The plasma LCN2 level was significantly elevated in patients with CAP before they received treatment compared to the controls (P < 0.001). (B) The plasma LCN2/MMP‐9 complex level was significantly elevated in patients with CAP before they received treatment compared to the controls (P < 0.001) and significantly decreased after the CAP patients received treatment (P < 0.001).